Items where Author is "Bertoni, Francesco"

2015

Cmiljanovic, Vladimir and Cmiljanovic, Natasa and Marone, Romina and Beaufils, Florent and Zhang, Xuxiao and Zvelebil, Marketa and Hebeisen, Paul and Lang, Marc and Mestan, Juergen and Melone, Anna and Bohnacker, Thomas and Gaudio, Eugenio and Tarantelli, Chiara and Bertoni, Francesco and Ritschard, Reto and Pretre, Vincent and Wicki, Andreas and Fabbro, Doriano and Hillmann, Petra and Williams, Roger and Giese, Bernd and Wymann, Matthias P.. (2015) PQR309: Structure-based design, synthesis and biological evaluation of a novel, selective, dual pan-PI3K/mTOR inhibitor. Cancer Research, 75 (15). p. 2664.

Tarantelli, Chiara and Gaudio, Eugenio and Kwee, Ivo and Rinaldi, Andrea and Bernasconi, Elena and Cascione, Luciano and Hillmann, Petra and Stathis, Anastasios and Carrassa, Laura and Broggini, Massimo and Stussi, Georg and Fabbro, Doriano and Beaufils, Florent and Melone, Anna and Bohnacker, Thomas and Wymann, Matthias P. and Wicki, Andreas and Zucca, Emanuele and Cmiljanovic, Vladimir and Bertoni, Francesco. (2015) Pre-clinical activity and mechanism of action of the novel dual PI3K/mTOR inhibitor PQR309 in B-cell lymphomas. Cancer Research, 75 (15). p. 2652.

2011

Rinaldi, Andrea and Mian, Michael and Chigrinova, Ekaterina and Arcaini, Luca and Bhagat, Govind and Novak, Urban and Rancoita, Paola M. V. and De Campos, Cassio P. and Forconi, Francesco and Gascoyne, Randy D. and Facchetti, Fabio and Ponzoni, Maurilio and Govi, Silvia and Ferreri, Andrés J. M. and Mollejo, Manuela and Piris, Miguel A. and Baldini, Luca and Soulier, Jean and Thieblemont, Catherine and Canzonieri, Vincenzo and Gattei, Valter and Marasca, Roberto and Franceschetti, Silvia and Gaidano, Gianluca and Tucci, Alessandra and Uccella, Silvia and Tibiletti, Maria Grazia and Dirnhofer, Stephan and Tripodo, Claudio and Doglioni, Claudio and Dalla Favera, Riccardo and Cavalli, Franco and Zucca, Emanuele and Kwee, Ivo and Bertoni, Francesco. (2011) Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome. Blood, Vol. 117, H. 5. pp. 1595-1604.